NCAM1 and glioma: Similarly, the frequency of CD56+/CD69+ NK cells in patients with Hsp70high grade 3 glioma was significantly higher than that in the controls (** p < 0.01, Figure 6B), whereas there was no difference between patients with Hsp70low grade 3 glioma and the controls.